Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 953 Indiana Street, San Francisco,ca 94107,united States
- Phone
- 217-766-4292
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- revelpharmaceuticals.com
- Keywords
- Technician jobs.
- HQ
- San Francisco, CA
Revel Pharmaceuticals Questions
Revel Pharmaceuticals's helpline number is 217-766-4292
Revel Pharmaceuticals's website is revelpharmaceuticals.com
Revel Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/revel-pharmaceuticals
Revel Pharmaceuticals has
9 employees.
View email and phone details for 9
employees at Revel Pharmaceuticals.
Revel Pharmaceuticals's industry is
Biotechnology Research
Revel Pharmaceuticals's top competitors are
Alixia,
Moglingbio Inc,
Orca Bio,
Centenara Labs Ag,
Denali Therapeutics,
Juvenescence®,
Cyclarity Therapeutics,
Arsenal Biosciences, Inc.,
Gordian Biotechnology,
Sutro Biopharma, Inc..
Revel Pharmaceuticals's categories are Biotechnology Research
Revel Pharmaceuticals's founding year is 2019
